Benjamin Besse, MD, PhD, Institut Gustave Roussy, Villejuif, France, discusses in which cases chemotherapy in combination with immunotherapy, immunotherapy alone, or a combination of immunotherapies are correct. Dr Besse believes each approach can benefit different subsets of patients. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.
